CVS Well being Corp (CVS.N), greatest identified for its nationwide chain of drugstores, stated on Thursday it had began providing scientific research companies to assist drug builders with duties resembling affected person enrollment.
The corporate stated it will use analytics and local people connections to assist people find out about scientific research alternatives that may very well be acceptable for them.
The brand new enterprise can even provide decentralized choices for late-stage scientific trials and research in real-world settings at CVS areas, at dwelling or just about, CVS stated.
Sure current challenges with conducting scientific research, resembling low affected person enrollment and inconvenient trial websites, present the necessity to enhance the present mannequin, significantly in response to the COVID-19 pandemic, stated Troyen Brennan, the chief medical officer of CVS Well being.
CVS stated it had already collaborated with drug builders to assist facilitate scientific trials for investigational COVID-19 vaccines and coverings, which the brand new enterprise will now increase. (https://refini.tv/3fvQaTi)
Our Requirements: The Thomson Reuters Trust Principles.